homovanillic acid has been researched along with Aging in 122 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using percutaneously placed arterial and venous catheters, we examined the influence of aging on the plasma concentration, whole body production rate, and renal clearance of homovanillic acid (HVA) in 60 healthy adult volunteers." | 7.69 | The influence of aging on the plasma concentration and renal clearance of homovanillic acid. ( Eisenhofer, G; Esler, MD; Lambert, GW, 1994) |
| "The aging of the cochlear dopaminergic system has been analyzed by quantifying the levels of dopamine (DA) and its metabolites (3,4-dihydroxyphenylacetic acid, DOPAC, and homovanillic acid, HVA) in adult rats aged 3, 12 or 24 months." | 3.71 | Effects of aging on cochlear monoamine turnover. ( Dávila, D; Gil-Loyzaga, P; Muñoz, E; Vicente-Torres, MA, 2002) |
| " In addition, the exposure to new environmental condition elevated blood corticosterone levels and enhanced behavioral activities to a greater extent in the Dex group than in controls at 7 wk of life, suggesting that elevated glucocorticoid levels during the pregnancy mimicked prenatal mild stress, producing developmental alterations in brain monoamine metabolism, endocrine response, and behavior in adult offspring." | 3.69 | Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. ( Kamei, K; Kitera, K; Mikuni, M; Muneoka, K; Ogawa, T; Takahashi, K; Takigawa, M, 1997) |
| "To examine the possible causal contribution of normal or accelerated aging to the neurodegenerative process of Parkinson's disease, we measured the influence of aging on subregional striatal dopamine and homovanillic acid levels in postmortem brain of 23 neurologically and psychiatrically normal human subjects 14-92 years old." | 3.68 | Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. ( Deck, JH; Hornykiewicz, O; Kish, SJ; Rajput, A; Shannak, K, 1992) |
| " The results indicate that aging did not significantly alter the levels of norepinephrine (NE), dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in frontal (FCX), parietal (PCX) and occipital cortices (OCX)." | 3.68 | Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats. ( Friedman, E; Yeung, JM, 1991) |
| "The long-term effect of the parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central monoaminergic neurons in young (2-3 months) and aging (12 months) C57BL/6 mice has been studied using neurochemical and immunocytochemical techniques." | 3.68 | Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. ( Date, I; Felten, DL; Felten, SY, 1990) |
| "Measurements of dopamine (DA) and its metabolites in plasma (DA sulfate) and urine (homovanillic acid) as well as its urinary response to furosemide revealed two distinct patterns: a hyperdopaminergic state in borderline essential hypertension (EH) and a renal DA deficiency in stable EH." | 3.68 | Peripheral dopamine in essential hypertension. An early defense against hypertension failing during its progression? ( Kuchel, O, 1990) |
| " Neither cortical NE nor its metabolite methoxyhydroxyphenylglycol sulphate (MHPG-SO4) were significantly changed by aging." | 3.67 | Effect of aging on monoamines and their metabolites in the rat brain. ( Carfagna, N; Moretti, A; Trunzo, F, 1987) |
| "Noradrenaline, dopamine, homovanillic acid (HVA), choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) levels were measured in post-mortem brains from 8 cases of pre-senile Alzheimer-type dementia (ATD), 5 cases of senile ATD, 4 cases of Down's syndrome aged 53-57 years, one 27-year-old case of Down's syndrome and 13 controls." | 3.66 | Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. ( Allison, Y; Gordon, A; Maloney, AF; Ritchie, IM; Simpson, J; Urquhart, A; Yates, CM, 1983) |
| "Withaferin A (WA) was evaluated for its neuro-protective efficacy on ageing induced striatal dopamine (DA) and behavioural changes in aged rats." | 1.51 | Ameliorative Effect of Withaferin A on Ageing-Mediated Impairment in the Dopamine System and Its Associated Behavior of Wistar Albino Rat. ( Ibrahim, M; Prabhu, K; Rajasankar, S; Raziya Banu, M, 2019) |
| "Levodopa (l-DOPA, l-3,4-dihydroxyphenylalanine) is the most effective drug in the symptomatic treatment of Parkinson's disease (PD), but chronic use initiates a maladaptive process leading to l-DOPA-induced dyskinesia (LID)." | 1.46 | Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia. ( Andersen, AD; Binzer, M; Blaabjerg, M; Gramsbergen, JBP; Kamal, A; Kjaer, TW; Stenager, E; Thagesen, H, 2017) |
| "Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder of mature and older individuals." | 1.36 | Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. ( Charlton, CG; King, J; Mackey, V; Muthian, G, 2010) |
| "Idiopathic Parkinson's disease (PD) is associated with advanced age, but it is still unclear whether dopaminergic neuronal death results from events initiated during development, adulthood, or represents a cumulative effect across the span of life." | 1.31 | Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. ( Baggs, RB; Cory-Slechta, DA; Goodman, BM; Richfield, EK; Thiruchelvam, M, 2002) |
| " Although increasing the dosage of d-METH (20 to 80 mg/kg) did increase the GFAP response (100% over control), it was still well below that usually exhibited at the usual neurotoxic dosage (300-400% over control) in fully mature mice." | 1.31 | Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. ( Ali, SF; Miller, DB; O'Callaghan, JP, 2000) |
| " A treatment history of high AMPH dosage was associated with a marked sensitization of the exploratory behavior in adults, whereas it induced a quite opposite profile in periadolescents." | 1.31 | Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats. ( Laviola, G; Pascucci, T; Pieretti, S, 2001) |
| "The Fragile X syndrome, a common form of mental retardation in humans, is caused by silencing the fragile X mental retardation (FMR1) gene leading to the absence of the encoded fragile X mental retardation protein 1 (FMRP)." | 1.31 | Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. ( Braun, K; Gruss, M, 2001) |
| "Sodium azide is an inhibitor of cytochrome oxidase which produces selective striatal lesions in both rodents and primates." | 1.29 | Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. ( Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P, 1994) |
| " These results suggest that SAM rapidly undergoes neurochemical changes which are considered to be part of the normal aging process, and these changes were attenuated by chronic administration of nimodipine." | 1.29 | Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. ( Kabuto, H; Mori, A; Murakami, M; Sawada, S; Yokoi, I, 1995) |
| " Eighteen-day-old rats were 35% and 63% more sensitive than adults to the effects of haloperidol on striatal and accumbens turnover and had steeper dose-response curves." | 1.29 | Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. ( Baldessarini, RJ; Barber, NI; Campbell, A; Gallitano, AL; Gelbard, HA; Marsh, E; Teicher, MH, 1993) |
| " A dose-response effect of apomorphine on extracellular dopamine was observed in all age groups except at 10-11 days of age." | 1.29 | The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release. ( Andersen, SL; Gazzara, RA, 1993) |
| "The effects of neonatal hydrocephalus on the levels of tyrosine, tryptophan, 5-hydroxyindoleacetic acid (5-HIAA), and homovanillic acid (HVA) in CSF were determined by high-performance liquid chromatography (HPLC) with fluorometric detection in normal and chronically hydrocephalic rabbits." | 1.29 | Neuroamine related compounds in the CSF of hydrocephalic rabbits. ( Faull, KF; Fisher, RS; Fluharty, AL; Gayek, RJ; Lazareff, JA; Olmstead, CE; Orlino, EN; Peacock, WJ; Wehby-Grant, MC, 1995) |
| "There is some evidence that Parkinson's disease (PD) seems to be a heterogenous and generalized brain disorder reflecting a degeneration of multiple neuronal networks, including somatostatinergic neurons." | 1.29 | Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa. ( Cramer, H; Hamann, GF; Schimrigk, K; Strittmatter, M; Strubel, D, 1996) |
| " Part 1 of the study established a dose-response curve and the temporal pattern of GSH loss and recovery in the substantia nigra and striatum following acute BSO treatment." | 1.29 | Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. ( Andersen, JK; Hamill, RW; Harnish, P; Hom, DG; Lee, FY; McNeill, TH; Mo, JQ, 1996) |
| "Biogenic amines in pons and striatum have been dosed in twenty-four months old Wistar male rats." | 1.27 | [Biochemical changes in 24-month-old Wistar rats]. ( Della Zuana, O; Duhault, J; Lonchampt, M; Roman, F; Saint Romas, G, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (27.87) | 18.7374 |
| 1990's | 51 (41.80) | 18.2507 |
| 2000's | 27 (22.13) | 29.6817 |
| 2010's | 10 (8.20) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raziya Banu, M | 1 |
| Ibrahim, M | 1 |
| Prabhu, K | 1 |
| Rajasankar, S | 1 |
| Pierno, S | 1 |
| Tricarico, D | 1 |
| Liantonio, A | 1 |
| Mele, A | 1 |
| Digennaro, C | 1 |
| Rolland, JF | 1 |
| Bianco, G | 1 |
| Villanova, L | 1 |
| Merendino, A | 1 |
| Camerino, GM | 1 |
| De Luca, A | 1 |
| Desaphy, JF | 1 |
| Camerino, DC | 1 |
| Li, Y | 1 |
| Sun, Y | 1 |
| Yang, J | 1 |
| Wu, Y | 1 |
| Yu, J | 1 |
| Li, B | 1 |
| Andersen, AD | 1 |
| Blaabjerg, M | 1 |
| Binzer, M | 1 |
| Kamal, A | 1 |
| Thagesen, H | 1 |
| Kjaer, TW | 1 |
| Stenager, E | 1 |
| Gramsbergen, JBP | 1 |
| Niimi, K | 1 |
| Takahashi, E | 1 |
| Itakura, C | 1 |
| Ling, Z | 1 |
| Zhu, Y | 1 |
| Tong, CW | 1 |
| Snyder, JA | 1 |
| Lipton, JW | 2 |
| Carvey, PM | 2 |
| Hunter, RL | 1 |
| Liu, M | 1 |
| Choi, DY | 1 |
| Cass, WA | 1 |
| Bing, G | 1 |
| Heermann, S | 1 |
| Opazo, F | 1 |
| Falkenburger, B | 1 |
| Krieglstein, K | 1 |
| Spittau, B | 1 |
| Muthian, G | 1 |
| Mackey, V | 1 |
| King, J | 1 |
| Charlton, CG | 1 |
| Oyama, G | 1 |
| Yoshimi, K | 1 |
| Natori, S | 1 |
| Chikaoka, Y | 1 |
| Ren, YR | 1 |
| Funayama, M | 1 |
| Shimo, Y | 1 |
| Takahashi, R | 1 |
| Nakazato, T | 1 |
| Kitazawa, S | 1 |
| Hattori, N | 1 |
| Allen, E | 1 |
| Carlson, KM | 1 |
| Zigmond, MJ | 1 |
| Cavanaugh, JE | 1 |
| Schumm, S | 1 |
| Sebban, C | 1 |
| Cohen-Salmon, C | 1 |
| Callebert, J | 1 |
| Launay, JM | 1 |
| Golmard, JL | 1 |
| Boussicault, L | 1 |
| Petropoulos, I | 1 |
| Hild, A | 1 |
| Rousselet, E | 1 |
| Prigent, A | 1 |
| Friguet, B | 1 |
| Mariani, J | 1 |
| Hirsch, EC | 1 |
| Baiguera, C | 1 |
| Alghisi, M | 1 |
| Pinna, A | 1 |
| Bellucci, A | 1 |
| De Luca, MA | 1 |
| Frau, L | 1 |
| Morelli, M | 1 |
| Ingrassia, R | 1 |
| Benarese, M | 1 |
| Porrini, V | 1 |
| Pellitteri, M | 1 |
| Bertini, G | 1 |
| Fabene, PF | 1 |
| Sigala, S | 1 |
| Spillantini, MG | 1 |
| Liou, HC | 1 |
| Spano, PF | 1 |
| Pizzi, M | 1 |
| Miura, H | 1 |
| Qiao, H | 1 |
| Ohta, T | 1 |
| Thiruchelvam, M | 1 |
| Richfield, EK | 1 |
| Goodman, BM | 1 |
| Baggs, RB | 1 |
| Cory-Slechta, DA | 1 |
| Stanford, JA | 1 |
| Vorontsova, E | 1 |
| Surgener, SP | 1 |
| Gerhardt, GA | 2 |
| Fowler, SC | 1 |
| Haycock, JW | 1 |
| Becker, L | 1 |
| Ang, L | 1 |
| Furukawa, Y | 1 |
| Hornykiewicz, O | 2 |
| Kish, SJ | 2 |
| Rapoport, SI | 1 |
| Schapiro, MB | 1 |
| May, C | 1 |
| Segovia, G | 1 |
| Mora, F | 1 |
| Götz, ME | 1 |
| Malz, CR | 1 |
| Dirr, A | 1 |
| Blum, D | 1 |
| Gsell, W | 1 |
| Schmidt, S | 1 |
| Burger, R | 1 |
| Pohli, S | 1 |
| Riederer, P | 1 |
| Martí, MB | 1 |
| Cano, AH | 1 |
| Villareal, EM | 1 |
| Martínez, SG | 1 |
| Bernet, IM | 1 |
| Chanut, E | 1 |
| Labarthe, B | 1 |
| Lacroix, B | 1 |
| Noda, A | 1 |
| Gasdeblay, S | 1 |
| Bondier, JR | 1 |
| Versaux-Botteri, C | 1 |
| Arborelius, L | 1 |
| Eklund, MB | 1 |
| Roman, F | 1 |
| Della Zuana, O | 1 |
| Lonchampt, M | 1 |
| Saint Romas, G | 1 |
| Duhault, J | 1 |
| Simpkins, JW | 1 |
| Lasley, SM | 1 |
| Greenland, RD | 1 |
| Minnema, DJ | 1 |
| Michaelson, IA | 1 |
| Muramoto, O | 1 |
| Ando, K | 1 |
| Carlsson, A | 1 |
| Adolfsson, R | 2 |
| Aquilonius, SM | 1 |
| Gottfries, CG | 3 |
| Oreland, L | 1 |
| Svennerholm, L | 1 |
| Winblad, B | 2 |
| Seifert, WE | 1 |
| Foxx, JL | 1 |
| Butler, IJ | 1 |
| Ponzio, F | 3 |
| Calderini, G | 2 |
| Lomuscio, G | 2 |
| Vantini, G | 3 |
| Toffano, G | 2 |
| Algeri, S | 3 |
| Bareggi, SR | 1 |
| Franceschi, M | 1 |
| Bonini, L | 1 |
| Zecca, L | 1 |
| Smirne, S | 1 |
| Yoshino, K | 1 |
| Silverstein, FS | 1 |
| Donn, S | 1 |
| Buchanan, K | 1 |
| Johnston, MV | 1 |
| Yates, CM | 1 |
| Simpson, J | 1 |
| Gordon, A | 1 |
| Maloney, AF | 1 |
| Allison, Y | 1 |
| Ritchie, IM | 1 |
| Urquhart, A | 1 |
| Nakamura, S | 3 |
| Yamao, S | 1 |
| Iijima, S | 1 |
| Kaji, R | 1 |
| Kameyama, M | 1 |
| Miyata, S | 2 |
| Itoh, J | 1 |
| Mimori, Y | 1 |
| Achilli, G | 1 |
| Cimino, M | 1 |
| Perego, C | 1 |
| Venero, JL | 3 |
| Machado, A | 7 |
| Cano, J | 7 |
| Brouillet, E | 1 |
| Hyman, BT | 1 |
| Jenkins, BG | 1 |
| Henshaw, DR | 1 |
| Schulz, JB | 1 |
| Sodhi, P | 1 |
| Rosen, BR | 1 |
| Beal, MF | 1 |
| Irwin, I | 1 |
| DeLanney, LE | 1 |
| McNeill, T | 1 |
| Chan, P | 1 |
| Forno, LS | 1 |
| Murphy, GM | 1 |
| Di Monte, DA | 1 |
| Sandy, MS | 1 |
| Langston, JW | 1 |
| Gupta, M | 1 |
| Wiener, HL | 1 |
| Kabuto, H | 1 |
| Yokoi, I | 1 |
| Mori, A | 1 |
| Murakami, M | 1 |
| Sawada, S | 1 |
| Cole, M | 1 |
| Craft, AW | 1 |
| Parker, L | 1 |
| Bell, S | 1 |
| Seviour, JA | 1 |
| McGill, AC | 1 |
| Dale, G | 1 |
| Erdtsieck-Ernste, EB | 1 |
| Feenstra, MG | 1 |
| Botterblom, M | 1 |
| Boer, GJ | 1 |
| Santiago, M | 4 |
| Martinez, M | 1 |
| Arnalich, F | 1 |
| Vazquez, JJ | 1 |
| Hernanz, A | 1 |
| Dorce, VA | 1 |
| Palermo-Neto, J | 1 |
| Ali, SF | 5 |
| David, SN | 1 |
| Newport, GD | 1 |
| Cadet, JL | 1 |
| Slikker, W | 1 |
| Tani, Y | 1 |
| Fernell, E | 1 |
| Watanabe, Y | 1 |
| Kanai, T | 1 |
| Långström, B | 1 |
| Tsai, YF | 1 |
| Tsai, HW | 1 |
| Tai, MY | 1 |
| Budygin, EA | 1 |
| Kovalev, GI | 1 |
| Gaĭntdinov, RR | 1 |
| Kudrin, VS | 2 |
| Voronina, TA | 1 |
| Tsuchida, K | 1 |
| Ujike, H | 1 |
| Kanzaki, A | 1 |
| Fujiwara, Y | 1 |
| Akiyama, K | 1 |
| Joseph, SA | 1 |
| Walker, DW | 1 |
| Teicher, MH | 1 |
| Barber, NI | 1 |
| Gelbard, HA | 1 |
| Gallitano, AL | 1 |
| Campbell, A | 1 |
| Marsh, E | 1 |
| Baldessarini, RJ | 1 |
| Andersen, SL | 1 |
| Gazzara, RA | 1 |
| Rose, S | 2 |
| Nomoto, M | 1 |
| Jackson, EA | 1 |
| Gibb, WR | 1 |
| Jaehnig, P | 1 |
| Jenner, P | 2 |
| Marsden, CD | 2 |
| Cabib, S | 1 |
| Puglisi-Allegra, S | 1 |
| D'Amato, FR | 1 |
| Olmstead, CE | 1 |
| Lazareff, JA | 1 |
| Orlino, EN | 1 |
| Fluharty, AL | 1 |
| Faull, KF | 2 |
| Peacock, WJ | 1 |
| Wehby-Grant, MC | 1 |
| Gayek, RJ | 1 |
| Fisher, RS | 1 |
| Hastings, JA | 2 |
| Pavia, JM | 2 |
| Morris, MJ | 2 |
| Strittmatter, M | 1 |
| Hamann, GF | 1 |
| Strubel, D | 1 |
| Cramer, H | 1 |
| Schimrigk, K | 1 |
| Andersen, JK | 1 |
| Mo, JQ | 1 |
| Hom, DG | 1 |
| Lee, FY | 1 |
| Harnish, P | 1 |
| Hamill, RW | 1 |
| McNeill, TH | 1 |
| Ueda, Y | 1 |
| Komatsu, M | 1 |
| Hiramatsu, M | 1 |
| Lambert, GW | 1 |
| Eisenhofer, G | 1 |
| Esler, MD | 1 |
| Muneoka, K | 1 |
| Mikuni, M | 1 |
| Ogawa, T | 1 |
| Kitera, K | 1 |
| Kamei, K | 1 |
| Takigawa, M | 1 |
| Takahashi, K | 1 |
| Philpot, RM | 2 |
| Kirstein, CL | 2 |
| Schneider, ML | 1 |
| Clarke, AS | 1 |
| Kraemer, GW | 2 |
| Roughton, EC | 1 |
| Lubach, GR | 1 |
| Rimm-Kaufman, S | 1 |
| Schmidt, D | 1 |
| Ebert, M | 1 |
| Maloney, RE | 1 |
| Pick, LH | 1 |
| Halperin, JM | 1 |
| Schwartz, ST | 1 |
| Newcorn, JH | 1 |
| Kucherianu, VG | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Iurasov, VV | 1 |
| Nikushkin, EV | 1 |
| Zhigal'tsev, IV | 1 |
| Ling, ZD | 1 |
| Collier, TJ | 1 |
| Sortwell, CE | 1 |
| Vu, TQ | 1 |
| Robie, HC | 1 |
| Shui, H | 1 |
| Peng, Y | 1 |
| Wu, R | 1 |
| Tsai, Y | 1 |
| Miller, DB | 1 |
| O'Callaghan, JP | 1 |
| Mandavilli, BS | 1 |
| Van Houten, B | 1 |
| Lee, JJ | 1 |
| Chang, CK | 1 |
| Liu, IM | 1 |
| Chi, TC | 1 |
| Yu, HJ | 1 |
| Cheng, JT | 1 |
| Laviola, G | 1 |
| Pascucci, T | 1 |
| Pieretti, S | 1 |
| Takeuchi, Y | 1 |
| Matsushita, H | 1 |
| Sakai, H | 1 |
| Kawano, H | 1 |
| Ochi, M | 1 |
| Goettl, VM | 1 |
| Wemlinger, TA | 1 |
| Colvin, AE | 1 |
| Neff, NH | 1 |
| Hadjiconstantinou, M | 1 |
| Ferreira, A | 1 |
| Bettencourt, P | 1 |
| Pestana, M | 1 |
| Correia, F | 1 |
| Serrão, P | 1 |
| Martins, L | 1 |
| Cerqueira-Gomes, M | 1 |
| Soares-Da-Silva, P | 1 |
| Imam, SZ | 1 |
| Vicente-Torres, MA | 2 |
| Muñoz, E | 2 |
| Dávila, D | 2 |
| Gil-Loyzaga, P | 2 |
| Gruss, M | 1 |
| Braun, K | 1 |
| Meyer, JS | 1 |
| Muskiet, FA | 1 |
| Fremouw-Ottevangers, DC | 1 |
| van der Meulen, J | 1 |
| Wolthers, BG | 1 |
| de Vries, JA | 1 |
| Roos, BE | 1 |
| Davis, AJ | 1 |
| Holzbauer, M | 1 |
| Sharman, DF | 1 |
| Raleigh, MJ | 1 |
| Brammer, GL | 1 |
| McGuire, MT | 1 |
| Pollack, DB | 1 |
| Yuwiler, A | 1 |
| Howells, DW | 1 |
| Hyland, K | 1 |
| Smith, I | 1 |
| Strobel, S | 1 |
| Pasinetti, GM | 1 |
| Osterburg, HH | 1 |
| Kelly, AB | 1 |
| Kohama, S | 1 |
| Morgan, DG | 1 |
| Reinhard, JF | 1 |
| Stellwagen, RH | 1 |
| Finch, CE | 1 |
| Arai, H | 1 |
| Ichimiya, Y | 1 |
| Kosaka, K | 1 |
| Moroji, T | 1 |
| Iizuka, R | 1 |
| Martineau, J | 1 |
| Garreau, B | 1 |
| Barthélémy, C | 1 |
| Jouve, J | 1 |
| Lelord, G | 1 |
| Higley, JD | 1 |
| Suomi, SJ | 1 |
| Linnoila, M | 1 |
| Takahashi, S | 1 |
| Abe, T | 1 |
| Taylor, MD | 1 |
| de Ceballos, ML | 1 |
| Chong, PN | 1 |
| Davis, BA | 1 |
| Durden, DA | 1 |
| O'Reilly, RL | 1 |
| Shannak, K | 1 |
| Rajput, A | 1 |
| Deck, JH | 1 |
| Yeung, JM | 1 |
| Friedman, E | 1 |
| Date, I | 1 |
| Felten, DL | 1 |
| Felten, SY | 1 |
| Godefroy, F | 1 |
| Bassant, MH | 1 |
| Lamour, Y | 1 |
| Weil-Fugazza, J | 1 |
| Kuchel, O | 1 |
| Walters, DE | 1 |
| Chapman, CD | 1 |
| Howard, SG | 1 |
| Hedner, J | 1 |
| Lundell, KH | 1 |
| Breese, GR | 1 |
| Mueller, RA | 1 |
| Hedner, T | 1 |
| Sunderland, T | 1 |
| Tariot, PN | 1 |
| Cohen, RM | 1 |
| Newhouse, PA | 1 |
| Mellow, AM | 1 |
| Mueller, EA | 1 |
| Murphy, DL | 1 |
| Moretti, A | 2 |
| Carfagna, N | 2 |
| Trunzo, F | 2 |
| Reinoso-Suárez, F | 1 |
| Vaughn, DM | 1 |
| Smyth, GB | 1 |
| Whitmer, WL | 1 |
| Satjawatcharaphong, C | 1 |
| Ebert, MH | 1 |
| Schmidt, DE | 1 |
| McKinney, WT | 1 |
| Stahl, SM | 1 |
| Thiemann, S | 1 |
| Barchas, JD | 1 |
| Berger, PA | 1 |
| MacRae, PG | 1 |
| Spirduso, WW | 1 |
| Walters, TJ | 1 |
| Farrar, RP | 1 |
| Wilcox, RE | 1 |
| Kumami, K | 1 |
| Mrsulja, BB | 1 |
| Ueki, Y | 1 |
| Djuricić, BD | 1 |
| Spatz, M | 1 |
| Hunneman, DH | 1 |
| Jonas, W | 1 |
| Gabriel, M | 1 |
| Gahr, M | 1 |
| Cousin, KM | 1 |
| Gerald, MC | 1 |
| Uretsky, NJ | 1 |
2 reviews available for homovanillic acid and Aging
| Article | Year |
|---|---|
[Biogenic amines and aging (author's transl)].
Topics: Adult; Aged; Aging; Alzheimer Disease; Biogenic Amines; Brain; Catecholamines; Homovanillic Acid; Hu | 1981 |
Human brain levels of monoamines and their metabolites. Postmortem investigations.
Topics: Adolescent; Adult; Affective Symptoms; Aging; Autopsy; Brain Chemistry; Catecholamines; Child; Dopam | 1980 |
120 other studies available for homovanillic acid and Aging
| Article | Year |
|---|---|
Ameliorative Effect of Withaferin A on Ageing-Mediated Impairment in the Dopamine System and Its Associated Behavior of Wistar Albino Rat.
Topics: Age Factors; Aging; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopaminergic Neurons; Homo | 2019 |
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function.
Topics: Administration, Oral; Aging; Animals; Antioxidants; Brain; Calcium; Chloride Channels; Gallic Acid; | 2014 |
Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Atrazine; Corpus Striatum; Dopamine; Dopamine Plasma | 2014 |
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aging; Antiparkinson Agents; Catecholamines; Dopamine; | 2017 |
Analysis of motor function and dopamine systems of SAMP6 mouse.
Topics: Aging; Analysis of Variance; Animals; Brain; Cerebellum; Dopamine; Homovanillic Acid; Male; Mice; Mi | 2009 |
Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Body Weight; Brai | 2009 |
Inflammation and age-related iron accumulation in F344 rats.
Topics: Age Factors; Aging; Animals; Dopamine; Endotoxins; Ferritins; Homovanillic Acid; Inflammation; Iron; | 2008 |
Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Chromatography, High Pressure | 2010 |
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Birth | 2010 |
Impaired in vivo dopamine release in parkin knockout mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Corpus Striatum; Dopamine; Homovanillic | 2010 |
L-DOPA reverses motor deficits associated with normal aging in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Dopamine; Dopamine Agents; H | 2011 |
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; An | 2012 |
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.
Topics: Aging; alpha-Synuclein; Animals; Cell Count; Corpus Striatum; Dopamine; Dopaminergic Neurons; Homova | 2012 |
Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Chromatography, High Pre | 2002 |
Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype.
Topics: Aging; Animals; Animals, Newborn; Body Weight; Cell Count; Chromatography, High Pressure Liquid; Dop | 2002 |
Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: exacerbation by nomifensine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Corpus Striatum; | 2002 |
Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Aromatic-L-Amino-Acid Decarboxylases | 2003 |
Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood-Brain Barrier; Brain Chemistry; Female; Homovanillic Ac | 2004 |
Dopamine and GABA increases produced by activation of glutamate receptors in the nucleus accumbens are decreased during aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Ana | 2005 |
Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animal Migration; Animals; Antioxidants; Apoptosis; Brain; Ca | 2005 |
Brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Artifacts; Brain; Cerebrospinal Fluid; Dopamine; Down-Regulat | 2005 |
Variations of dopamine, serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Animals, Newborn; Biogenic Monoamines; | 2006 |
Both long and brief maternal separation produces persistent changes in tissue levels of brain monoamines in middle-aged female rats.
Topics: Aging; Animals; Biogenic Monoamines; Brain; Depressive Disorder; Dopamine; Down-Regulation; Female; | 2007 |
[Biochemical changes in 24-month-old Wistar rats].
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aging; Animals; Choline; Choline O-Acetyltrans | 1984 |
Regional changes in monoamine metabolism in the aging constant estrous rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Corpus Striatum; Dopamine; Estrus; Female; Ho | 1984 |
Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Erythrocytes; Female; Homovanillic | 1984 |
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
Topics: 5-Methoxytryptamine; Adult; Aged; Aging; Alcoholism; Brain; Dementia; Dopamine; Homovanillic Acid; H | 1980 |
Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Topics: Adolescent; Adult; Aging; Child; Child, Preschool; Glycols; Homovanillic Acid; Humans; Hydroxyindole | 1980 |
Changes in monoamines and their metabolite levels in some brain regions of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleace | 1982 |
Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?
Topics: Age Factors; Aged; Aging; Alzheimer Disease; Brain Chemistry; Dementia; Female; gamma-Aminobutyric A | 1982 |
[Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aged; Aging; Biogenic Amines; Chromatography, Hig | 1982 |
Changes with age in rat central monoaminergic system responses to cold stress.
Topics: Aging; Animals; Body Temperature Regulation; Brain; Brain Stem; Cold Temperature; Corticosterone; Do | 1982 |
Concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid from human infants in the perinatal period.
Topics: Aging; Female; Gestational Age; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Infant, | 1984 |
Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
Topics: Acetylcholinesterase; Adult; Aged; Aging; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dem | 1983 |
[Age-related changes in nervous system].
Topics: Adult; Aged; Aging; Cerebrospinal Fluid; Electroencephalography; Evoked Potentials, Somatosensory; G | 1984 |
Study on some compensatory responses of dopaminergic system in aging rats.
Topics: Aging; Animals; Apomorphine; Butyrophenones; Corpus Striatum; Feedback; Haloperidol; Homovanillic Ac | 1982 |
Effect of ageing on monoamine turnover in the prefrontal cortex of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Homovanillic Acid; Hy | 1993 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Cor | 1994 |
Aging and the nigrostriatal dopamine system: a non-human primate study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analys | 1994 |
Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; | 1995 |
Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Aging; Animals; Brain; Calcium | 1995 |
Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Body Height; Body Weight; Child; Child, Preschool | 1995 |
Postnatal exposure to the beta-adrenoceptor agonist clenbuterol has regionally selective direct and long-term effects on rat brain beta-adrenoceptors and monoamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Brain; Cerebellum; Clenbuterol; Do | 1993 |
Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialys | 1993 |
Altered cerebrospinal fluid amino acid pattern in the anorexia of aging: relationship with biogenic amine metabolism.
Topics: Aged; Aged, 80 and over; Aging; Amino Acids; Anorexia; Biogenic Amines; Body Weight; Female; Homovan | 1993 |
Behavioral and neurochemical changes induced by aging in dopaminergic systems of male and female rats.
Topics: Aging; Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Female; Homovanillic Acid; | 1994 |
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbre | 1994 |
Decrease in 6R-5,6,7,8-tetrahydrobiopterin content in cerebrospinal fluid of autistic patients.
Topics: Adolescent; Adult; Aging; Autistic Disorder; Biopterins; Child; Child, Preschool; Female; Homovanill | 1994 |
Comparison of brain dopamine depletion induced by low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in young and aged rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; | 1994 |
[Age-related changes in the dopaminergic system in rat striatum].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal Metabolism; Corpus Striatum; Dopamine; Homovan | 1993 |
Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Brain Chemistry; Chromatography, H | 1994 |
Monoamine concentrations in cerebrospinal fluid of fetal and newborn sheep.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Biogenic Monoamines; Dinoprostone; | 1994 |
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Dose-Response Relationshi | 1993 |
The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apomorphine; Corpus Striatum; Dopamine; Dose-Respons | 1993 |
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Callithrix; Chromatography, | 1993 |
Effects of postnatal stress on dopamine mesolimbic system responses to aversive experiences in adult life.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Apomorphine; Dopamine; Female; | 1993 |
Neuroamine related compounds in the CSF of hydrocephalic rabbits.
Topics: Aging; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Homovanillic Acid; Hydro | 1995 |
Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Homovanillic Acid; Male; Norepinephr | 1996 |
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
Topics: Aged; Aged, 80 and over; Aging; Biogenic Monoamines; Dementia; Female; Homovanillic Acid; Humans; Hy | 1996 |
Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Buthionine Sulfoximine; Corpus Striatu | 1996 |
Free radical scavenging activity of the Japanese herbal medicine toki-shakuyaku-san (TJ-23) and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Bepridil; Biogenic Monoamines; Biphenyl | 1996 |
Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cerebral Ventricles; Drug Synergism; Homovanillic Ac | 1997 |
The influence of aging on the plasma concentration and renal clearance of homovanillic acid.
Topics: Adolescent; Adult; Aged; Aging; Female; Glomerular Filtration Rate; Homovanillic Acid; Humans; Male; | 1994 |
Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Cortex; Aging; Analysis of Variance; Animals; Biogenic Monoa | 1997 |
The effects of repeated alcohol exposure on the neurochemistry of the periadolescent nucleus accumbens septi.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alcoholism; Animals; Dopamine; Dose-Response Relationship, Dr | 1998 |
Prenatal stress alters brain biogenic amine levels in primates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Biogenic Amines; Brain; Female; Ho | 1998 |
Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Corpus Striatum; Dextroampheta | 1999 |
A longitudinal study of neurobiological mechanisms in boys with attention-deficit hyperactivity disorder: preliminary findings.
Topics: Aging; Attention Deficit Disorder with Hyperactivity; Blood Platelets; Brain; Catecholamines; Child; | 1999 |
Repeated cocaine exposure: effects on catecholamines in the nucleus accumbens septi of periadolescent animals.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Cocaine; Dopamine; Dopamine Uptake I | 1999 |
[Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Administration, Intran | 1999 |
Striatal trophic activity is reduced in the aged rat brain.
Topics: Aging; Animals; Brain; Cells, Cultured; Chromatography, High Pressure Liquid; Corpus Striatum; Dopam | 2000 |
Evaluation of L-DOPA biotransformation during repeated L-DOPA infusion into the striatum in freely-moving young and old rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antiparkinson Agents; Chromatography, High Pressure | 2000 |
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Area Under Curve; Body Temperature; Central Nervous | 2000 |
DNA damage in brain mitochondria caused by aging and MPTP treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Brain Chemistry; DNA Damage; DNA, Mitoc | 2000 |
Changes in endogenous monoamines in aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Catechol O-Methyltransferase; C | 2001 |
Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Caud | 2001 |
Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy.
Topics: Adolescent; Age Factors; Aging; Biogenic Monoamines; Case-Control Studies; Child; Child, Preschool; | 2001 |
Motoric behavior in aged rats treated with GM1.
Topics: Aging; Animals; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Male; Motor Activity; Movement Disor | 2001 |
Heart failure, aging, and renal synthesis of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Age Factors; Aged; Aging; Aldosterone; Cardiac Output, Low; C | 2001 |
Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain Chemistry; Central Nervous System Stimulants; | 2001 |
Changes in the cochlear dopaminergic system of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Cochlea; Dopam | 2001 |
Effects of aging on cochlear monoamine turnover.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Chromatography, High Pressure L | 2002 |
Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain St | 2001 |
Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apoptosis; Brain; Dopamine; Female; Homovanillic Aci | 2002 |
Determination of some L-3,4-dihydroxyphenylalanine and dopamine metabolites in urine by means of mass fragmentography.
Topics: 3-Methoxy-4-hydroxyphenylethanol; 3,4-Dihydroxyphenylacetic Acid; Adult; Aging; Child; Child, Presch | 1978 |
Cathecholamines in the human brain and ageing.
Topics: Aged; Aging; Alzheimer Disease; Autopsy; Brain; Dementia; Dopamine; Homovanillic Acid; Humans; Norep | 1977 |
Postnatal development of dopamine deamination in the striatum of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Deamination; Dopamine; Female; Homo | 1975 |
Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
Topics: Aging; Animals; Body Weight; Chlorocebus aethiops; Diet; Female; Homovanillic Acid; Hydroxyindoleace | 1992 |
Tryptophan and serotonin metabolism in familial erythrophagocytic lymphohistiocytosis.
Topics: Aging; Amino Acids; Biopterins; Child, Preschool; Etoposide; Histiocytosis, Non-Langerhans-Cell; Hom | 1992 |
Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acid Sequence; Animals; Biogenic Monoamines; Corpus Str | 1992 |
Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Chemistry; Choline O-Acetyltransferase; Hom | 1992 |
[Development in the metabolism of dopamine and its derivatives. Application to gross development disorders].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Autistic Disorder; Child; Child, Presch | 1992 |
Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydraz | 1991 |
CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys.
Topics: Aging; Animals; Biogenic Monoamines; Cisterna Magna; Female; Homovanillic Acid; Hydroxyindoleacetic | 1991 |
[Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
Topics: Adolescent; Adult; Aged; Aging; Biogenic Monoamines; Child; Chromatography, High Pressure Liquid; Do | 1991 |
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal | 1991 |
The effect of age, sex, weight and height on the plasma concentrations in healthy subjects of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders.
Topics: Adult; Aged; Aging; Biogenic Monoamines; Body Height; Body Weight; Female; Homovanillic Acid; Humans | 1991 |
Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Corpus Striatum; Dopamine; | 1992 |
Age effects on monoamine turnover of the rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Aromatic Amino Acid Decarboxyla | 1991 |
Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Biogenic Monoamines; Cerebral Cortex; C | 1991 |
Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; | 1990 |
Effect of aging on dopamine metabolism in the rat cerebral cortex: a regional analysis.
Topics: Aging; Animals; Cerebral Cortex; Dopamine; Homovanillic Acid; Male; Norepinephrine; Rats; Rats, Inbr | 1991 |
Peripheral dopamine in essential hypertension. An early defense against hypertension failing during its progression?
Topics: Aging; Dopamine; Furosemide; Homovanillic Acid; Humans; Hypertension; Longitudinal Studies; Renin | 1990 |
Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Female; Haloper | 1990 |
Developmental variations in CSF monoamine metabolites during childhood.
Topics: Adolescent; Aging; Biogenic Amines; Child; Child, Preschool; Female; Glycols; Homovanillic Acid; Hum | 1986 |
[Neurotransmitters and degenerative diseases in the central nervous system].
Topics: Acetylcholinesterase; Aged; Aging; Brain Diseases; Dementia; Dopamine; Homovanillic Acid; Humans; Hy | 1986 |
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Huma | 1987 |
Effect of aging on monoamines and their metabolites in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Dopamine; Homovanillic Acid; | 1987 |
Changes in biogenic amines in rat hippocampus during development and aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Dopamine; Hippocampus; Homovani | 1988 |
Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Cisterna Magna; Female; Homovan | 1989 |
A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Amines; Female; Homovanillic Acid; Hydroxyi | 1989 |
Age-related changes of catecholamines and their metabolites content in the visual system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Dopamine; Geniculate Bodies; Homovan | 1989 |
[Ageing and neurotransmitters].
Topics: Acetylcholine; Aged; Aging; Alzheimer Disease; Animals; Brain; Choline O-Acetyltransferase; Dopamine | 1985 |
Neurochemistry of dopamine in Huntington's dementia and normal aging.
Topics: Adult; Aged; Aging; Brain; Dementia; Dopamine; Homovanillic Acid; Humans; Huntington Disease; Male; | 1986 |
Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Kineti | 1987 |
Effect of ischemia on noradrenergic and energy-related metabolites in the cerebral cortex of young and adult gerbils.
Topics: Aging; Animals; Cerebral Cortex; Gerbillinae; Glucose; Homovanillic Acid; Ischemic Attack, Transient | 1988 |
Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma.
Topics: Adolescent; Adult; Aging; Child; Child, Preschool; Fetal Blood; Homovanillic Acid; Humans; Infant; I | 1986 |
The change with age in biogenic amines and their metabolites in the striatum of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Biogenic Amines; Corpus Striatum; Dopam | 1986 |
Effect of nialamide on the metabolism of dopamine injected into the nucleus accumbens of old rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Homovanillic Acid; Limbic System; Male; Mo | 1986 |
Brain catecholamine content and turnover in aging rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; alpha-Methyltyrosine; Animals; Brain; Catecholamines; Corpus | 1985 |